Petri dish showing antibiotic resistance testing.

Ceftaroline Resistance: Are Current Testing Methods Missing the Mark?

Nico Varela in Health & Wellness June 2025 • 4 min read.

"A closer look at how revised disk diffusion breakpoints may not accurately detect emerging resistance in Staphylococcus aureus."

Antimicrobial susceptibility testing is crucial in guiding effective treatment strategies, especially as antibiotic resistance continues to rise. Ceftaroline, a broad-spectrum cephalosporin, is a key player in combating resistant strains of Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA). However, accurately detecting ceftaroline resistance remains a challenge, and recent research suggests that standard testing methods may not always provide a clear picture.

The Clinical and Laboratory Standards Institute (CLSI) provides guidelines for determining antibiotic breakpoints, which are critical values used to classify bacteria as susceptible, intermediate, or resistant to a particular drug. Disk diffusion, a commonly used method, involves measuring the zone of inhibition around an antibiotic disk on a bacterial culture. These measurements are then compared to established breakpoints to determine susceptibility.

A recent study published in the Journal of Clinical Microbiology has raised concerns about the effectiveness of revised ceftaroline disk diffusion breakpoints in accurately identifying ceftaroline resistance in Staphylococcus aureus. The study evaluated the performance of these breakpoints against a collection of MRSA isolates, including those with decreased susceptibility to ceftaroline. This article delves into the findings of this research and discusses the implications for clinical practice.

Understanding the Study: Ceftaroline Disk Diffusion and MRSA

Petri dish showing antibiotic resistance testing.

The study, led by Sader et al., assessed the ability of revised CLSI ceftaroline disk diffusion breakpoints to correlate with ceftaroline MIC (minimum inhibitory concentration) values obtained through broth microdilution, the reference method. They tested a challenge collection of 158 MRSA isolates, including 106 randomly selected isolates and 52 isolates known to have decreased susceptibility to ceftaroline (MIC, 1–16 µg/mL).

Disk diffusion was performed using 30-µg ceftaroline disks and Mueller-Hinton agar from two different manufacturers. The researchers applied the revised CLSI MIC breakpoints (≤1/2-4/28 µg/mL for susceptible/susceptible dose-dependent/resistant) and evaluated the error rates associated with the disk diffusion method.

MIC (Minimum Inhibitory Concentration): The lowest concentration of an antibiotic that inhibits the growth of a microorganism.
Broth Microdilution: A reference method for determining MIC values by exposing bacteria to different concentrations of antibiotics in a liquid medium.
Disk Diffusion: A method for determining antibiotic susceptibility by measuring the zone of inhibition around an antibiotic disk on a bacterial culture.
Breakpoints: Established values used to interpret MIC or disk diffusion results and classify bacteria as susceptible, intermediate, or resistant.

The researchers also investigated the genetic mechanisms of ceftaroline resistance by sequencing the PBP2a gene and the upstream region of pbp4 in selected isolates. Mutations in these regions have been associated with decreased ceftaroline susceptibility. The goal was to determine whether isolates with specific mutations were accurately identified as resistant by the disk diffusion method.

Implications for Clinical Practice and Future Directions

The study highlights the importance of ongoing surveillance and refinement of antibiotic susceptibility testing methods to ensure accurate detection of resistance. As bacteria continue to evolve and develop new mechanisms of resistance, it is crucial to adapt testing strategies accordingly. Further research is needed to explore alternative testing methods and to identify novel biomarkers that can predict ceftaroline resistance with greater accuracy. By improving our ability to detect and understand ceftaroline resistance, we can optimize treatment strategies and protect the effectiveness of this important antibiotic.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1128/jcm.00777-18, Alternate LINK

Title: Evaluation Of The Revised Ceftaroline Disk Diffusion Breakpoints When Testing A Challenge Collection Of Methicillin-Resistant Staphylococcus Aureus Isolates

Subject: Microbiology (medical)

Journal: Journal of Clinical Microbiology

Publisher: American Society for Microbiology

Authors: Helio S. Sader, Paul R. Rhomberg, Timothy B. Doyle, Robert K. Flamm, Rodrigo E. Mendes

Published: 2018-12-01

Everything You Need To Know

What is the role of ceftaroline in treating infections, and why is accurately detecting resistance so important?

Ceftaroline is a broad-spectrum cephalosporin used to combat resistant strains of Staphylococcus aureus, specifically methicillin-resistant S. aureus (MRSA). Accurately detecting ceftaroline resistance is critical because it directly impacts treatment strategies. If resistance is not correctly identified, patients may receive ineffective treatment, leading to treatment failure and the spread of resistant bacteria. Effective treatment relies on knowing whether the bacteria are susceptible to the antibiotic, and this is determined by the antibiotic susceptibility testing.

What are 'breakpoints' and how are they used in antibiotic susceptibility testing, with specific reference to the methods mentioned?

Breakpoints are established values provided by the Clinical and Laboratory Standards Institute (CLSI) used to interpret results from antibiotic susceptibility tests. These values classify bacteria as susceptible, intermediate, or resistant to a particular drug. In the context of ceftaroline and Staphylococcus aureus, two key methods are used. Disk diffusion involves measuring the zone of inhibition around a ceftaroline disk on a bacterial culture, and the measurement is then compared to the breakpoints to determine susceptibility. The broth microdilution method is used as a reference for determining the Minimum Inhibitory Concentration (MIC), which is then compared with CLSI breakpoints.

Describe the study by Sader et al. and what specific methods did they use to assess ceftaroline resistance in MRSA?

The study by Sader et al. assessed the accuracy of revised CLSI ceftaroline disk diffusion breakpoints in detecting ceftaroline resistance in Staphylococcus aureus. They compared disk diffusion results with ceftaroline MIC values obtained through broth microdilution, the reference method. The study included 158 MRSA isolates, including isolates with decreased susceptibility to ceftaroline. They also investigated the genetic mechanisms of ceftaroline resistance by sequencing the PBP2a gene and the upstream region of pbp4 in selected isolates to determine the accuracy of the disk diffusion method.

What are the implications of the study's findings for clinical practice and how might they influence future research?

The study's findings highlight that standard testing methods may not always accurately identify ceftaroline resistance in Staphylococcus aureus. This has significant implications for clinical practice as inaccurate results can lead to treatment failures. The study underscores the importance of ongoing surveillance and refinement of antibiotic susceptibility testing methods. Future research is needed to explore alternative testing methods and identify novel biomarkers that can predict ceftaroline resistance with greater accuracy. This will help optimize treatment strategies and protect the effectiveness of ceftaroline.

Can you explain the difference between Disk Diffusion and Broth Microdilution methods in the context of ceftaroline susceptibility testing?

Both Disk Diffusion and Broth Microdilution are methods used to determine the susceptibility of Staphylococcus aureus to ceftaroline, but they work differently. Disk Diffusion involves placing a ceftaroline disk on a bacterial culture and measuring the zone of inhibition—the area where bacterial growth is prevented. The size of this zone is then compared to established breakpoints. Broth Microdilution, on the other hand, involves exposing bacteria to different concentrations of ceftaroline in a liquid medium. The Minimum Inhibitory Concentration (MIC) is determined, which is the lowest concentration of ceftaroline that inhibits bacterial growth. Broth Microdilution is considered the reference method, providing a more precise measurement of ceftaroline's effectiveness against the bacteria.